FLT3 and acute myeloid leukemia: A retrospective analysis of 3082 AML patients found that FLT3-TKD had no significant influence on OS or event-free survival (EFS) [18], while a meta-analysis found that both mutations have a negative prognostic impact on disease-free survival (DFS).